Squamous Cell Carcinoma of the Head and Neck
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Head and Neck.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN [Phase 2]
Phase 2 clinical trial updating weekly carboplatin, paclitaxel, and cetuximab for recurrent or metastatic squamous cell carcinoma of the hea…
-
CLINICAL_TRIALS trial_result · 2020-07-02Clinical Trial Update: ADXS 11-001 Vaccination Prior to Robotic Surgery, HPV-Positive Oropharyngeal Cancer [Phase 2]
Phase 2 clinical trial evaluating ADXS-11-001 vaccination before robotic surgery in HPV-positive oropharyngeal squamous cell carcinoma has c…
-
CLINICAL_TRIALS trial_result · 2020-04-10Clinical Trial Update: Stereotactic Body Radiotherapy for Head and Neck Tumors [Phase 4]
Phase 4 clinical trial update on stereotactic body radiotherapy for head and neck tumors with completed status and posted results in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase II trial evaluating palbociclib with carboplatin for unresectable recurrent or metastatic head and neck squamous cell carcinoma has co…
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck [Phase 2]
Phase 2 safety and tolerability update for AlloVax in metastatic or recurrent head and neck cancer (squamous cell carcinoma) has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) [Phase 2]
Phase 2 trial of docetaxel, cisplatin, and cetuximab (TPC) in palliative treatment for head and neck squamous cell carcinoma has completed w…
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors [Phase 1, Phase 2]
A dose-escalation and cohort-expansion study evaluating anti-CD27 (Varlilumab) with anti-PD-1 (Nivolumab) in advanced refractory solid tumor…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN） [Phase 3]
Phase 3 trial update for TQB2450 in recurrent or metastatic squamous cell cancer of the head and neck is in progress, with status currently …
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 trial evaluating chemotherapy plus cetuximab with VTX-2337 in recurrent/metastatic squamous cell carcinoma of the head and neck has …
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors [Phase 1, Phase 2]
A phase 1/2 study evaluating PLX3397 in combination with pembrolizumab in advanced melanoma and other solid tumors was terminated; results w…
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer [Phase 2]
Phase 2 trial update on reproducibility of intratumor distribution of 18F-EF5 in head and neck cancer (squamous cell carcinoma).
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking History [Phase 1]
Phase 1 clinical trial evaluating olaparib with radiation therapy and cetuximab in advanced head and neck squamous cell carcinoma with heavy…
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer [Phase 2]
Phase 2 trial evaluating palbociclib plus cetuximab versus cetuximab alone for squamous cell carcinoma of the head and neck, completed with …
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Changes in Body Composition After EPA Supplementation in Head and Neck Patients [Phase 3]
Phase 3 clinical trial update on EPA supplementation showing changes in body composition in head and neck cancer patients.
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck [Phase 2]
Phase 2 randomized trial evaluating beet root in locally advanced squamous cell carcinoma of the head and neck; study completed with results…
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck [Phase 2]
Phase 2 clinical trial investigating paclitaxel (albumin-bound) with bleomycin and cisplatin or carboplatin for recurrent or metastatic squa…
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY232 / KEYNOTE-137) [Phase 1]
A Phase 1 trial evaluating talimogene laherparepvec in combination with pembrolizumab for recurrent metastatic squamous cell carcinoma of th…
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: Erlotinib,Radiation and Cisplatin in Patients With Complete Resected Squamous Cell Carcinoma of the Head and Neck [Phase 3]
Phase 3 trial evaluating erlotinib with radiation and cisplatin in patients with completely resected squamous cell carcinoma of the head and…
-
CLINICAL_TRIALS trial_result · 2019-04-29Clinical Trial Update: NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]
Clinical trial update for NC-6004 in combination with 5-FU and cetuximab in recurrent/metastatic squamous cell carcinoma of the head and nec…
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Hyperbaric Radiation Sensitization of Head and Neck Cancers [Phase 2]
Phase 2 study evaluating hyperbaric oxygen–assisted radiation sensitization in squamous cell carcinoma of the head and neck; no results are …
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: InductionChemo-Radio-Antibody-Treatment [Phase 2]
A Phase 2 trial of induction chemo-radiation-antibody therapy for squamous cell carcinoma of the head and neck has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck [Phase 2]
The document notes the completion of a Phase 2 neoadjuvant window trial evaluating afatinib in squamous cell carcinoma of the head and neck.
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase II study evaluating MEDI4736 (durvalumab) with tremelimumab in combination for recurrent/metastatic squamous cell carcinoma of the hea…
-
CLINICAL_TRIALS trial_result · 2018-06-18Clinical Trial Update: Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase II study results for MEDI4736 monotherapy in recurrent/metastatic PD-L1-positive squamous cell carcinoma of the head and neck have bee…
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Genes [Phase 2]
Phase 2 trial of SF1126 in patients with recurrent or progressive squamous cell carcinoma of the head and neck bearing mutations in PIK3CA o…